Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 39

    1.

    Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein.

    Voss K, Stahl S, Hogan BM, Reinders J, Schleider E, Schulte-Merker S, Felbor U.

    Hum Mutat. 2009 Jun;30(6):1003-11.PMID: 19370760 [PubMed - indexed for MEDLINE]Related articles

    2.

    A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.

    Pagenstecher A, Stahl S, Sure U, Felbor U.

    Hum Mol Genet. 2009 Mar 1;18(5):911-8. Epub 2008 Dec 16.PMID: 19088124 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.

    Stahl S, Gaetzner S, Voss K, Brackertz B, Schleider E, Sürücü O, Kunze E, Netzer C, Korenke C, Finckh U, Habek M, Poljakovic Z, Elbracht M, Rudnik-Schöneborn S, Bertalanffy H, Sure U, Felbor U.

    Hum Mutat. 2008 May;29(5):709-17.PMID: 18300272 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Genetics of cerebral cavernous malformations (CCM)]

    Felbor U.

    Dtsch Med Wochenschr. 2007 Sep;132(38):1967-70. Review. German. No abstract available. PMID: 17853352 [PubMed - indexed for MEDLINE]Related articles

    5.

    Proteomic analysis of cathepsin B- and L-deficient mouse brain lysosomes.

    Stahl S, Reinders Y, Asan E, Mothes W, Conzelmann E, Sickmann A, Felbor U.

    Biochim Biophys Acta. 2007 Oct;1774(10):1237-46. Epub 2007 Jul 19.PMID: 17765022 [PubMed - indexed for MEDLINE]Related articles

    6.

    CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations.

    Voss K, Stahl S, Schleider E, Ullrich S, Nickel J, Mueller TD, Felbor U.

    Neurogenetics. 2007 Nov;8(4):249-56. Epub 2007 Jul 27.PMID: 17657516 [PubMed - indexed for MEDLINE]Related articles

    7.

    Large germline deletions and duplication in isolated cerebral cavernous malformation patients.

    Felbor U, Gaetzner S, Verlaan DJ, Vijzelaar R, Rouleau GA, Siegel AM.

    Neurogenetics. 2007 Apr;8(2):149-53. Epub 2007 Jan 9.PMID: 17211633 [PubMed - indexed for MEDLINE]Related articles

    8.

    CCM1 gene deletion identified by MLPA in cerebral cavernous malformation.

    Gaetzner S, Stahl S, Sürücü O, Schaafhausen A, Halliger-Keller B, Bertalanffy H, Sure U, Felbor U.

    Neurosurg Rev. 2007 Apr;30(2):155-9; discussion 159-60. Epub 2006 Dec 23.PMID: 17187287 [PubMed - indexed for MEDLINE]Related articles

    9.

    Clinical impact of CCM mutation detection in familial cavernous angioma.

    Sürücü O, Sure U, Gaetzner S, Stahl S, Benes L, Bertalanffy H, Felbor U.

    Childs Nerv Syst. 2006 Nov;22(11):1461-4. Epub 2006 Sep 16.PMID: 16983571 [PubMed - indexed for MEDLINE]Related articles

    10.

    Genetics of cerebral cavernous angioma.

    Felbor U, Sure U, Grimm T, Bertalanffy H.

    Zentralbl Neurochir. 2006 Aug;67(3):110-6. Review.PMID: 16958007 [PubMed - indexed for MEDLINE]Related articles

    11.

    Controversial molecular classification of human cerebrovascular malformations.

    Stahl S, Felbor U.

    Stroke. 2006 Sep;37(9):2214; author reply 2215-6. Epub 2006 Aug 3. No abstract available. PMID: 16888261 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    VEGF receptors on PC12 cells mediate transient activation of ERK1/2 and Akt: comparison of nerve growth factor and vascular endothelial growth factor.

    Berger I, Stahl S, Rychkova N, Felbor U.

    J Negat Results Biomed. 2006 Jun 1;5:8.PMID: 16737552 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Endostatin phenylalanines 31 and 34 define a receptor binding site.

    Stahl S, Gaetzner S, Mueller TD, Felbor U.

    Genes Cells. 2005 Sep;10(9):929-39.PMID: 16115201 [PubMed - indexed for MEDLINE]Related articles

    14.

    Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.

    Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM.

    Science. 2005 Jun 10;308(5728):1643-5. Epub 2005 Apr 14.PMID: 15831716 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explants.

    Gaetzner S, Deckers MM, Stahl S, Löwik C, Olsen BR, Felbor U.

    Matrix Biol. 2005 Jan;23(8):557-61. Epub 2004 Nov 19.PMID: 15694132 [PubMed - indexed for MEDLINE]Related articles

    16.

    Non-heparan sulfate-binding interactions of endostatin/collagen XVIII in murine development.

    Rychkova N, Stahl S, Gaetzner S, Felbor U.

    Dev Dyn. 2005 Feb;232(2):399-407.PMID: 15614762 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Sensitization to the lysosomal cell death pathway upon immortalization and transformation.

    Fehrenbacher N, Gyrd-Hansen M, Poulsen B, Felbor U, Kallunki T, Boes M, Weber E, Leist M, Jäättelä M.

    Cancer Res. 2004 Aug 1;64(15):5301-10.PMID: 15289336 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Mosaicism for an ectopic NOR at 8pter and a complex rearrangement of chromosome 8 in a patient with severe psychomotor retardation.

    Felbor U, Knötgen N, Schams G, Buwe A, Steinlein C, Schmid M.

    Cytogenet Genome Res. 2004;106(1):55-60.PMID: 15218242 [PubMed - indexed for MEDLINE]Related articles

    19.

    The rare human fragile site 16B.

    Felbor U, Feichtinger W, Schmid M.

    Cytogenet Genome Res. 2003;100(1-4):85-8. Review.PMID: 14526167 [PubMed - indexed for MEDLINE]Related articles

    20.

    Centromeric association of chromosome 16- and 18-derived microchromosomes.

    Felbor U, Rutschow D, Haaf T, Schmid M.

    Hum Genet. 2002 Jul;111(1):16-25. Epub 2002 Jun 13.PMID: 12136231 [PubMed - indexed for MEDLINE]Related articles

    21.

    Neuronal loss and brain atrophy in mice lacking cathepsins B and L.

    Felbor U, Kessler B, Mothes W, Goebel HH, Ploegh HL, Bronson RT, Olsen BR.

    Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7883-8. Epub 2002 Jun 4.PMID: 12048238 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    A nonsense mutation in MSX1 causes Witkop syndrome.

    Jumlongras D, Bei M, Stimson JM, Wang WF, DePalma SR, Seidman CE, Felbor U, Maas R, Seidman JG, Olsen BR.

    Am J Hum Genet. 2001 Jul;69(1):67-74. Epub 2001 May 16.PMID: 11369996 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Generation and degradation of human endostatin proteins by various proteinases.

    Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaissé J.

    FEBS Lett. 2000 Dec 15;486(3):247-51.PMID: 11119712 [PubMed - indexed for MEDLINE]Related articles

    24.

    Collagen XVIII/endostatin structure and functional role in angiogenesis.

    Zatterstrom UK, Felbor U, Fukai N, Olsen BR.

    Cell Struct Funct. 2000 Apr;25(2):97-101. Review.PMID: 10885579 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Secreted cathepsin L generates endostatin from collagen XVIII.

    Felbor U, Dreier L, Bryant RA, Ploegh HL, Olsen BR, Mothes W.

    EMBO J. 2000 Mar 15;19(6):1187-94.PMID: 10716919 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Allelic heterogeneity of alkaptonuria in Central Europe.

    Müller CR, Fregin A, Srsen S, Srsnova K, Halliger-Keller B, Felbor U, Seemanova E, Kress W.

    Eur J Hum Genet. 1999 Sep;7(6):645-51.PMID: 10482952 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Ocular ochronosis in alkaptonuria patients carrying mutations in the homogentisate 1,2-dioxygenase gene.

    Felbor U, Mutsch Y, Grehn F, Müller CR, Kress W.

    Br J Ophthalmol. 1999 Jun;83(6):680-3.PMID: 10340975 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Genomic organization and chromosomal localization of the interphotoreceptor matrix proteoglycan-1 (IMPG1) gene: a candidate for 6q-linked retinopathies.

    Felbor U, Gehrig A, Sauer CG, Marquardt A, Köhler M, Schmid M, Weber BH.

    Cytogenet Cell Genet. 1998;81(1):12-7.PMID: 9691169 [PubMed - indexed for MEDLINE]Related articles

    30.

    [Sorsby's fundus dystrophy. A genetically homogeneous disease]

    Felbor U, Weber BH.

    Ophthalmologe. 1998 May;95(5):287-90. German. PMID: 9643018 [PubMed - indexed for MEDLINE]Related articles

    31.

    Sorsby fundus dystrophy: reevaluation of variable expressivity in patients carrying a TIMP3 founder mutation.

    Felbor U, Benkwitz C, Klein ML, Greenberg J, Gregory CY, Weber BH.

    Arch Ophthalmol. 1997 Dec;115(12):1569-71.PMID: 9400791 [PubMed - indexed for MEDLINE]Related articles

    32.

    Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies.

    Felbor U, Doepner D, Schneider U, Zrenner E, Weber BH.

    Invest Ophthalmol Vis Sci. 1997 May;38(6):1054-9.PMID: 9152224 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Adult vitelliform macular dystrophy is frequently associated with mutations in the peripherin/RDS gene.

    Felbor U, Schilling H, Weber BH.

    Hum Mutat. 1997;10(4):301-9.PMID: 9338584 [PubMed - indexed for MEDLINE]Related articles

    34.

    Autosomal recessive Sorsby fundus dystrophy revisited: molecular evidence for dominant inheritance.

    Felbor U, Suvanto EA, Forsius HR, Eriksson AW, Weber BH.

    Am J Hum Genet. 1997 Jan;60(1):57-62.PMID: 8981947 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.

    Felbor U, Stöhr H, Amann T, Schönherr U, Apfelstedt-Sylla E, Weber BH.

    J Med Genet. 1996 Mar;33(3):233-6.PMID: 8728699 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Genomic organization of the human tissue inhibitor of metalloproteinases-3 (TIMP3)

    Stöhr H, Roomp K, Felbor U, Weber BH.

    Genome Res. 1995 Dec;5(5):483-7.PMID: 8808469 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy with unusual clinical features.

    Felbor U, Stöhr H, Amann T, Schönherr U, Weber BH.

    Hum Mol Genet. 1995 Dec;4(12):2415-6. No abstract available. PMID: 8634721 [PubMed - indexed for MEDLINE]Related articles

    38.

    Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.

    Weber BH, Vogt G, Pruett RC, Stöhr H, Felbor U.

    Nat Genet. 1994 Dec;8(4):352-6.PMID: 7894485 [PubMed - indexed for MEDLINE]Related articles

    39.

    [Not Available]

    Felbor U.

    Wurzbg Medizinhist Mitt. 1993;11:155-73. German. No abstract available. PMID: 11639872 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...